🤖 #1 in AI | Palantir Bullets #65
🤖 #1 in AI | Palantir Bullets #65
Dresner award in multiple categories, CEO Alex Karp interviews
👋 Hi, I’m Arny . Welcome to Palantir Bullets, the weekly recap to spot asymmetries.
Editor: Emanuele Marabella
Last week:
Palantir, the “AI impostor” according to
, wins the Dresner Advisory Services 2023 Technology Innovation Award in 8 categories:AI, Data Science, and Machine Learning;
Cloud Business Intelligence;
Supply Chain Planning and Analytics;
Data Engineering;
Self-Service Business Intelligence;
Model Ops;
Analytical Platforms;
Embedded BI.
Cleveland Clinic, one of the biggest US hospitals, praised Palantir’s AI in a dedicated article for its contribution to staffing, scheduling, and once-tedious tasks.
"The Virtual Command Center is one of the first projects to come from Cleveland Clinic’s partnership with Palantir; more are planned." - Cleveland Clinic
Palantir CEO Alex Karp wrote a new article in Time Magazine, "Silicon Valley Has a Harvard Problem.” He criticized Silicon Valley for their lack of interest in deploying the best minds and technologies to serve national interest. Dr. Karp’s book, “The Technological Republic” will be published next year.
“The problem is not a principled commitment to pacifism or nonviolence. It is a more fundamental abandonment of belief in anything. The employees who resisted leveraging the machinery of Google in service of building software for the U.S. military know what they oppose but not what they are for.” - Alex Karp, Palantir CEO, and Zamiska, Palantir Head of Corporate Affairs
CEO Alex Karp attended the World Governments Summit in Dubai (full interview). During the interview, he dropped a precious hint on the evolution of the Healthcare segment:
"We power almost 20% of hospitals in the US." - Alex Karp, Palantir CEO
CEO Alex Karp also attended the Munich Security Conference (full interview) to discuss AI, Regulation, and the World Order.
Palantir announced it will be the the lead sponsor at the inaugural AI Expo for National Competitiveness on May 7-8, 2024 in Washington DC. There could be some special guests…
HSBC downgraded Palantir to Hold from Buy with a price target of $22 per share on valuation concerns after a +50% rally in a couple of weeks.
Articles you could enjoy:
Palantweets
Tweet of the week
Yours,
Arny
Reach me:
Disclaimer: The views and opinions expressed above are current as of the date of this document and are subject to change without notice. Materials referenced above will be provided for educational purposes only. None of the above will include investment advice, a recommendation or an offer to sell, or a solicitation of an offer to buy, any securities or investment products